Lilly’s Olumiant, spurned by FDA, gets nod from NICE

30th June 2017 Uncategorised 0

Eli Lilly has won a nod from NICE for its anticipated blockbuster and Humira competitor, Olumiant, a modicum of good news for a drug the FDA rejected in April.

More: Lilly’s Olumiant, spurned by FDA, gets nod from NICE
Source: fierce